Nate Raymond

Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.

Twitter handle: @jeffmason1

4:32am IST

Firing for vaccine refusal not religious discrimination - 3rd Circuit

A federal appeals court ruled on Thursday that certain anti-vaccination beliefs are not religious in nature and cannot form the basis of a lawsuit claiming discrimination by an employee who refuses to get a flu shot.

4:31am IST

Boston Scientific loses bid to dismiss defibrillator whistleblower case

A federal judge has allowed to proceed a whistleblower lawsuit claiming Boston Scientific Corp caused doctors to make false claims for reimbursement from federal healthcare programs for two defective defibrillator products.

2:33am IST

DaVita pharmacy unit settles U.S. billing probe for $63.7 million

A pharmacy services unit of DaVita Inc will pay $63.7 million to resolve allegations that it improperly billed federal healthcare programs for medications and paid illegal financial inducements to patients, the U.S. Justice Department said.

14 Dec 2017

Case to Watch: second judge to weigh Trump birth control rules

For the second time in a week, a U.S. judge will hear arguments in a lawsuit challenging new rules by President Donald Trump’s administration that undermined an Obamacare requirement for employers to provide insurance that covers women's birth control.

14 Dec 2017

Pharmacy exec in 2012 meningitis outbreak seeks restitution delay

A Massachusetts pharmacy executive found guilty of racketeering for his role in a deadly 2012 meningitis outbreak is seeking to delay until after his appeal prosecutors' request that he be forced to pay $73.7 million in restitution to victims.

14 Dec 2017

Three U.S. men plead guilty to crimes tied to 2016 botnet attacks

A former Rutgers University student and two other men pleaded guilty to computer crimes related to the creation, sale and use of the Mirai botnet, a network of infected electronics equipment used to knock major websites offline in massive 2016 cyber attacks.

14 Dec 2017

Medtronic settles states' probe into Infuse marketing for $12 million

BOSTON Medtronic Plc has agreed to pay $12 million to resolve claims that the company engaged in a deceptive marketing strategy to promote its Infuse bone graft product used in spinal surgery, the Massachusetts attorney general said on Wednesday.

13 Dec 2017

Drug CEO used corporate cash for cosmetic surgery, clothes - SEC

U.S. securities regulators on Tuesday accused Provectus Biopharmaceuticals Inc's former chief executive of treating the drugmaker as his "personal piggy bank" and fraudulently using $3.2 million for clothing, trips to Hooters and other expenses.

13 Dec 2017

Massachusetts diagnostic lab cannot escape whistleblower case

A federal judge has declined to reconsider his decision not to dismiss a lawsuit claiming a diagnostic laboratory billed government healthcare programs for medically unnecessary tests to, but he acknowledged he previously overstated its legal obligations.

12 Dec 2017

Cosmetic testing firm in U.S. probe seeks search warrant documents

A New York cosmetic and personal care products testing company is fighting to unseal documents related to search warrants executed earlier this year as part of a federal investigation into whether the company falsified test-related records.


  • Asia
  • U.S.
  • Europe
  • Sectors
Stock Search
Sensex 33,246.70 -- --%
Nikkei 22,494.76 -199.69 -0.88%
Hang Seng 28,883.97 -282.41 -0.97%
EUR/INR 75.813 +0.07%
USD/INR 64.330 +0.00%
GBP/INR 86.427 +0.04%
Gold 1,253.10 -0.70 -0.06%
Oil 57.19 +0.15 +0.26%
Corn 336.25 +0.00 +0.00%